These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 26775068

  • 1. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
    Margiotta N, Savino S, Marzano C, Pacifico C, Hoeschele JD, Gandin V, Natile G.
    J Inorg Biochem; 2016 Jul; 160():85-93. PubMed ID: 26775068
    [Abstract] [Full Text] [Related]

  • 2. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N.
    Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897
    [Abstract] [Full Text] [Related]

  • 3. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S, Gandin V, Hoeschele JD, Marzano C, Natile G, Margiotta N.
    Dalton Trans; 2018 May 29; 47(21):7144-7158. PubMed ID: 29766157
    [Abstract] [Full Text] [Related]

  • 4. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.
    Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896
    [Abstract] [Full Text] [Related]

  • 5. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 6. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
    Tabrizi L, Thompson K, Mnich K, Chintha C, Gorman AM, Morrison L, Luessing J, Lowndes NF, Dockery P, Samali A, Erxleben A.
    Mol Pharm; 2020 Aug 03; 17(8):3009-3023. PubMed ID: 32628022
    [Abstract] [Full Text] [Related]

  • 7. Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration.
    Barbanente A, Gandin V, Ceresa C, Marzano C, Ditaranto N, Hoeschele JD, Natile G, Arnesano F, Pacifico C, Intini FP, Margiotta N.
    Int J Mol Sci; 2022 Jun 25; 23(13):. PubMed ID: 35806087
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z, Chan HM, Li C, Wang Z, Tse MK, Tong Z, Zhu G.
    Inorg Chem; 2018 Jul 16; 57(14):8227-8235. PubMed ID: 29943979
    [Abstract] [Full Text] [Related]

  • 9. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V, Marzano C, Pelosi G, Ravera M, Gabano E, Osella D.
    ChemMedChem; 2014 Jun 16; 9(6):1299-305. PubMed ID: 24715720
    [Abstract] [Full Text] [Related]

  • 10. Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy.
    Curci A, Gandin V, Marzano C, Hoeschele JD, Natile G, Margiotta N.
    Inorg Chem; 2017 Jul 03; 56(13):7482-7493. PubMed ID: 28636387
    [Abstract] [Full Text] [Related]

  • 11. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D.
    J Inorg Biochem; 2015 Sep 03; 150():1-8. PubMed ID: 26042542
    [Abstract] [Full Text] [Related]

  • 12. Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin.
    Fang T, Ye Z, Wu J, Wang H.
    Chem Commun (Camb); 2018 Aug 14; 54(66):9167-9170. PubMed ID: 30062328
    [Abstract] [Full Text] [Related]

  • 13. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X, Wang M, Wang C, Hu W, You Q, Yang Y, Yu C, Liao Z, Gou S, Wang H.
    Bioorg Chem; 2019 Nov 14; 92():103236. PubMed ID: 31494328
    [Abstract] [Full Text] [Related]

  • 14. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 14; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 15. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
    Göschl S, Varbanov HP, Theiner S, Jakupec MA, Galanski MS, Keppler BK.
    J Inorg Biochem; 2016 Jul 14; 160():264-74. PubMed ID: 27055943
    [Abstract] [Full Text] [Related]

  • 16. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug.
    Ma L, Wang N, Ma R, Li C, Xu Z, Tse MK, Zhu G.
    Angew Chem Int Ed Engl; 2018 Jul 16; 57(29):9098-9102. PubMed ID: 29806087
    [Abstract] [Full Text] [Related]

  • 17. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
    Montagner D, Tolan D, Andriollo E, Gandin V, Marzano C.
    Int J Mol Sci; 2018 Nov 27; 19(12):. PubMed ID: 30486477
    [Abstract] [Full Text] [Related]

  • 18. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 27; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 19. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
    Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D.
    J Med Chem; 2021 Aug 12; 64(15):11364-11378. PubMed ID: 34342437
    [Abstract] [Full Text] [Related]

  • 20. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D, Warnecke A, Kalayda GV, Kratz F, Jaehde U.
    J Control Release; 2008 Oct 21; 131(2):100-6. PubMed ID: 18691617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.